Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

WDFY1 anticorps (AA 261-357)

WDFY1 Reactivité: Humain ELISA, WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7175691
  • Antigène Voir toutes WDFY1 Anticorps
    WDFY1 (WD Repeat and FYVE Domain Containing 1 (WDFY1))
    Épitope
    • 16
    • 5
    • 4
    • 1
    • 1
    AA 261-357
    Reactivité
    • 20
    • 17
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 32
    • 1
    Lapin
    Clonalité
    • 33
    Polyclonal
    Conjugué
    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp WDFY1 est non-conjugé
    Application
    • 14
    • 13
    • 13
    • 8
    • 6
    • 5
    • 3
    • 2
    • 1
    ELISA, Western Blotting (WB)
     Réactivité croisée
    Humain, Souris
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human WD repeat and FYVE domain-containing protein 1 protein (261-357AA)
    Isotype
    IgG
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    WDFY1 (WD Repeat and FYVE Domain Containing 1 (WDFY1))
    Autre désignation
    WDFY1 (WDFY1 Produits)
    Synonymes
    anticorps FENS-1, anticorps WDF1, anticorps ZFYVE17, anticorps 1700013B03Rik, anticorps 1700120F24Rik, anticorps Jr1, anticorps mKIAA1435, anticorps MGC93914, anticorps zgc:101764, anticorps zgc:109909, anticorps WD repeat and FYVE domain containing 1, anticorps WDFY1, anticorps Wdfy1, anticorps wdfy1
    Sujet

    Background: Positively regulates TLR3- and TLR4-mediated signaling pathways by bridging the interaction between TLR3 or TLR4 and TICAM1. Promotes TLR3/4 ligand-induced activation of transcription factors IRF3 and NF-kappa-B, as well as the production of IFN-beta and inflammatory cytokines (PubMed:25736436).

    Aliases: FENS 1 antibody, FENS-1 antibody, FENS1 antibody, KIAA1435 antibody, Phosphoinositide binding protein 1 antibody, Phosphoinositide binding protein SR1 antibody, Phosphoinositide-binding protein 1 antibody, WD repeat and FYVE domain containing 1 antibody, WD repeat and FYVE domain-containing protein 1 antibody, WD40 and FYVE domain containing protein 1 antibody, WD40- and FYVE domain-containing protein 1 antibody, WDF1 antibody, WDFY1 antibody, WDFY1_HUMAN antibody, ZFYVE17 antibody, Zinc finger FYVE domain containing protein 17 antibody, Zinc finger FYVE domain-containing protein 17 antibody

    UniProt
    Q8IWB7
Vous êtes ici:
Support technique